Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications
about
Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guidelineTriglycerides as vascular risk factors: new epidemiologic insightsOpening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular riskMolecular processes that handle -- and mishandle -- dietary lipidsImaging of coronary atherosclerosis in various susceptible groupsThe role of the lymphatic system in cholesterol transportAtherosclerosis in psoriatic disease: latest evidence and clinical implicationsOxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosisApoptotic cell clearance: basic biology and therapeutic potential.Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspectiveAnti-inflammatory therapy in chronic disease: challenges and opportunitiesA point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive CardiologyUnderstanding the role of B cells in atherosclerosis: potential clinical implicationsSphingolipid signaling in metabolic disordersInvolvement of heparanase in atherosclerosis and other vessel wall pathologiesMucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J miceTrafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal DomainAction mechanism and cardiovascular effect of anthocyanins: a systematic review of animal and human studiesEgg phospholipids and cardiovascular healthRecent developments in the management of dry age-related macular degenerationPCSK9 Inhibition With Monoclonal Antibodies: Modern Management of HypercholesterolemiaFenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemiaT cell costimulatory and coinhibitory pathways in vascular inflammatory diseasesRole of superoxide radical anion in the mechanism of apoB100 degradation induced by DHA in hepatic cellsImmunity, atherosclerosis and cardiovascular diseaseAchieving secondary prevention low-density lipoprotein particle concentration goals using lipoprotein cholesterol-based dataSummation of blood glucose and TAG to characterise the 'metabolic load index'.Smooth muscle cell-specific deletion of Col15a1 unexpectedly leads to impaired development of advanced atherosclerotic lesions.Recent insights into the cellular biology of atherosclerosisABC Transport Proteins in Cardiovascular Disease-A Brief Summary.Contrast Ultrasound Imaging Does Not Affect Heat Shock Protein 70 Expression in Cholesterol-Fed Rabbit Aorta.LOX-1 ligands containing apolipoprotein B and carotid intima-media thickness in middle-aged community-dwelling US Caucasian and Japanese men.Emerging diagnostic and therapeutic molecular imaging applications in vascular diseasePerspectives and opportunities for nanomedicine in the management of atherosclerosis.Contrast ultrasound imaging of the aorta alters vascular morphology and circulating von Willebrand factor in hypercholesterolemic rabbits.Macrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins.Plasmin promotes foam cell formation by increasing macrophage catabolism of aggregated low-density lipoprotein.Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells.C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells.The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression.
P2860
Q24608464-8F8546EA-CA90-4D0F-BD42-FD62303C6AD8Q24618902-DDF78DC7-D497-40F3-BBE2-0920AF9A49FCQ24626884-2D162D1F-F541-41CE-9575-762000299B64Q24642118-EBD7CEF0-50FE-4604-937B-4614F21BD31BQ26738569-F4DF1A03-FF22-4C2F-8881-43887C24F265Q26782973-FFD07BEA-8C5A-489A-BC74-1CA2B6DDAD53Q26783501-F1BADD6F-8DA5-45AB-B88D-5BE8EDDC3FCDQ26822962-C7EFD287-7629-42A0-8DA9-623639512666Q26825935-4F483298-6CF9-41E8-A153-71CBD6DD3CFAQ26852364-DF7C8046-A362-4773-AAE7-A46D33AFBAC6Q26860162-4B6C9202-7A5F-4DCC-93F3-0C05E4C2B051Q26866033-3677B0C2-62AD-408D-AADC-7A187CF0F88FQ26991813-28A1CB09-C598-4B03-A6AC-0A93D37DBC1EQ26992148-F3426AB5-F016-4AD6-A253-DFB4E153FC0FQ27025052-0AD92857-0DF0-4A56-919E-F285F659AC6CQ27335174-23C597FB-56A1-4533-BEEB-E71DA617774CQ27339783-C768C42A-354F-4AF5-A942-EFA82F975551Q28077812-A71D4C3F-32EE-429C-8C2B-107B3B0F7E65Q28082796-3EE90091-0C0C-4DB7-89C3-B707ECFE0CE4Q28088816-BB145234-7D9E-4068-A2E3-782987A859B0Q28275648-E286F8AC-DB1B-4A26-9CA4-81EEF04676D3Q28284661-C55FCC83-0D53-47F5-BB1C-1E68F4240468Q28396774-085F58F5-023A-4D24-97DD-E20096F250F3Q28567216-5E234F49-1EEA-43D8-9833-387AB8F4ECC5Q28688590-E168C686-1C8C-40B3-A1E0-8AEA08C2CD90Q28730849-B3C95065-B6EC-47E2-940E-B6808D1FB54CQ30244149-938B3D0A-C909-4815-9E1F-DC8917CBBD3FQ30252988-A12F69EC-AEE9-4528-8738-5AF0AEF983A6Q30300194-EFA94607-129A-497B-A7D3-0C22B3643930Q30313271-B678DAE2-A3EA-4AD2-9A21-8B381C85C513Q30394923-223D7D23-F0BC-4F28-BE8D-1E6E1BAA9448Q30418436-BE46E5C8-FF8D-4092-B715-25CFFB5DE000Q30450437-80B5ED78-9D6A-4AD5-BAA8-6F8CFBD20032Q30455490-5015DB57-B5AB-4179-994B-5DFA6D2319CFQ30461916-6F77D290-6FD9-4723-A3DF-76C480FA6F8CQ30492073-EFF682A6-53E8-49EC-803A-E52448BD67AFQ30541611-BE965B8B-8B9B-4E76-92F6-C3DE7B256706Q30829602-2047548B-0F61-4105-8B64-E9D818D5EAC1Q33562207-1545BFF2-7AE0-419A-8158-DC0954999A4EQ33586616-3992F92F-DA9E-4851-99AF-9A48CEA14612
P2860
Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Subendothelial lipoprotein ret ...... e and therapeutic implications
@ast
Subendothelial lipoprotein ret ...... e and therapeutic implications
@en
Subendothelial lipoprotein ret ...... e and therapeutic implications
@nl
type
label
Subendothelial lipoprotein ret ...... e and therapeutic implications
@ast
Subendothelial lipoprotein ret ...... e and therapeutic implications
@en
Subendothelial lipoprotein ret ...... e and therapeutic implications
@nl
prefLabel
Subendothelial lipoprotein ret ...... e and therapeutic implications
@ast
Subendothelial lipoprotein ret ...... e and therapeutic implications
@en
Subendothelial lipoprotein ret ...... e and therapeutic implications
@nl
P3181
P1433
P1476
Subendothelial lipoprotein ret ...... e and therapeutic implications
@en
P2093
Kevin Jon Williams
P304
P3181
P356
10.1161/CIRCULATIONAHA.106.676890
P407
P50
P577
2007-10-16T00:00:00Z